Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's Disease

Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's Disease

Background & aims: Durable remissions of Crohn's Disease (CD) have followed myeloablative conditioning therapy and allogeneic marrow transplantation. For patients with treatment-refractory disease, we used reduced-intensity conditioning to minimize toxicity, marrow from donors with low...

Full description

Bibliographic Details
Main Authors: George B. McDonald, Ole J.B. Landsverk, Dermot P.B. McGovern, Anders Aasebø, Vemund Paulsen, Talin Haritunians, Henrik M. Reims, Bernadette M. McLaughlin, Timothy Zisman, Dalin Li, Elisabeth T.M.M. Elholm, Frode L. Jahnsen, George E. Georges, Tobias Gedde-Dahl
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Heliyon
Subjects:
Mucosal immune chimerism
Polygenic risk score
Outcomes
Reduced-intensity conditioning
Crohn's disease
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024000574

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024000574

Similar Items